Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane M Da Silva

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Vaccine|April 24, 2019
Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated diseaseDiane M Da Silva, Joseph G Skeate, Elena Chavez-Juan, et al.
Cells|April 25, 2020
The Essential Role of anxA2 in Langerhans Cell Birbeck Granules FormationShantae M Thornton, Varsha D Samararatne, Joseph G Skeate, et al.
The Prostate|November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytesLisa Yan, Diane M Da Silva, Bhavna Verma, et al.
Scientific Reports|August 5, 2018
Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradationJulia R Taylor, Daniel J Fernandez, Shantaé M Thornton, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infectionAndrew W Woodham, Julia R Taylor, Andrew I Jimenez, et al.
Papillomavirus Research (Amsterdam, Netherlands)|May 17, 2016
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulationAndrew W Woodham, Lisa Yan, Joseph G Skeate, et al.
Human Immunology|August 23, 2005
Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitroDominic E Warrino, Walter C Olson, Meera I Scarrow, et al.
Frontiers in Immunology|November 6, 2020
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid ClusteringJoseph G Skeate, Wouter H Segerink, Mauricio D Garcia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 11, 2014
Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppressionAndrew W Woodham, Adam B Raff, Laura M Raff, et al.
Plos One|August 29, 2012
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionAndrew W Woodham, Diane M Da Silva, Joseph G Skeate, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Vaccine|April 24, 2019
Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated diseaseDiane M Da Silva, Joseph G Skeate, Elena Chavez-Juan, et al.
Cells|April 25, 2020
The Essential Role of anxA2 in Langerhans Cell Birbeck Granules FormationShantae M Thornton, Varsha D Samararatne, Joseph G Skeate, et al.
The Prostate|November 18, 2014
Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytesLisa Yan, Diane M Da Silva, Bhavna Verma, et al.
Scientific Reports|August 5, 2018
Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradationJulia R Taylor, Daniel J Fernandez, Shantaé M Thornton, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Small molecule inhibitors of the annexin A2 heterotetramer prevent human papillomavirus type 16 infectionAndrew W Woodham, Julia R Taylor, Andrew I Jimenez, et al.
Papillomavirus Research (Amsterdam, Netherlands)|May 17, 2016
T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulationAndrew W Woodham, Lisa Yan, Joseph G Skeate, et al.
Human Immunology|August 23, 2005
Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitroDominic E Warrino, Walter C Olson, Meera I Scarrow, et al.
Frontiers in Immunology|November 6, 2020
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid ClusteringJoseph G Skeate, Wouter H Segerink, Mauricio D Garcia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 11, 2014
Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppressionAndrew W Woodham, Adam B Raff, Laura M Raff, et al.
Plos One|August 29, 2012
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionAndrew W Woodham, Diane M Da Silva, Joseph G Skeate, et al.
Pageof 7